309 related articles for article (PubMed ID: 27481051)
21. Association of mismatch repair deficiency with PTEN frameshift mutations in endometrial cancers and the precursors in a Japanese population.
Kanaya T; Kyo S; Sakaguchi J; Maida Y; Nakamura M; Takakura M; Hashimoto M; Mizumoto Y; Inoue M
Am J Clin Pathol; 2005 Jul; 124(1):89-96. PubMed ID: 15923161
[TBL] [Abstract][Full Text] [Related]
22. Reversal of the malignant phenotype of ovarian cancer A2780 cells through transfection with wild-type PTEN gene.
Wu H; Wang S; Weng D; Xing H; Song X; Zhu T; Xia X; Weng Y; Xu G; Meng L; Zhou J; Ma D
Cancer Lett; 2008 Nov; 271(2):205-14. PubMed ID: 18662848
[TBL] [Abstract][Full Text] [Related]
23. The relationship between microsatellite instability and PTEN gene mutations in endometrial cancer.
Bilbao C; Rodríguez G; Ramírez R; Falcón O; León L; Chirino R; Rivero JF; Falcón O; Díaz-Chico BN; Díaz-Chico JC; Perucho M
Int J Cancer; 2006 Aug; 119(3):563-70. PubMed ID: 16506206
[TBL] [Abstract][Full Text] [Related]
24. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.
Xu B; Hamada S; Kusuki I; Itoh R; Kitawaki J
Gynecol Oncol; 2011 Feb; 120(2):239-46. PubMed ID: 21130491
[TBL] [Abstract][Full Text] [Related]
25. Prediction of functionally significant single nucleotide polymorphisms in PTEN tumor suppressor gene: An in silico approach.
Khan I; Ansari IA; Singh P; Dass J FP
Biotechnol Appl Biochem; 2017 Sep; 64(5):657-666. PubMed ID: 26800850
[TBL] [Abstract][Full Text] [Related]
26. [Expressions of Livin and PTEN in Cancerous Tissues of Ovary Endometriosis].
Liu XY; Wang HJ; Xu P; Chen J; Pan HY; Liu Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Jul; 47(4):512-515. PubMed ID: 28591952
[TBL] [Abstract][Full Text] [Related]
27. Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia.
Sun H; Enomoto T; Fujita M; Wada H; Yoshino K; Ozaki K; Nakamura T; Murata Y
Am J Clin Pathol; 2001 Jan; 115(1):32-8. PubMed ID: 11190805
[TBL] [Abstract][Full Text] [Related]
28. Bioinformatic analysis of protein structure-function relationships: case study of leukocyte elastase (ELA2) missense mutations.
Thusberg J; Vihinen M
Hum Mutat; 2006 Dec; 27(12):1230-43. PubMed ID: 16986121
[TBL] [Abstract][Full Text] [Related]
29. Comparative Protein Structural Network Analysis Reveals C-Terminal Tail Phosphorylation Structural Communication Fingerprint in
Smith IN; Dawson JE; Eng C
J Phys Chem B; 2023 Jan; 127(3):634-647. PubMed ID: 36626331
[TBL] [Abstract][Full Text] [Related]
30. Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis.
Martini M; Ciccarone M; Garganese G; Maggiore C; Evangelista A; Rahimi S; Zannoni G; Vittori G; Larocca LM
Int J Cancer; 2002 Dec; 102(4):398-406. PubMed ID: 12402310
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors.
Philip CA; Laskov I; Beauchamp MC; Marques M; Amin O; Bitharas J; Kessous R; Kogan L; Baloch T; Gotlieb WH; Yasmeen A
BMC Cancer; 2017 Sep; 17(1):638. PubMed ID: 28886696
[TBL] [Abstract][Full Text] [Related]
32. Somatic mutations of the PTEN/NMAC1 gene associated with frequent chromosomal loss detected using comparative genomic hybridization in endometrial cancer.
Hirai Y; Tanaka N; Furuta R; Kawaguchi T; Sakamoto M; Shirahama S; Noda T
Gynecol Oncol; 2001 Oct; 83(1):81-8. PubMed ID: 11585417
[TBL] [Abstract][Full Text] [Related]
33. Role of endometriosis in cancer and tumor development.
Swiersz LM
Ann N Y Acad Sci; 2002 Mar; 955():281-92; discussion 293-5, 396-406. PubMed ID: 11949955
[TBL] [Abstract][Full Text] [Related]
34. Genetic derangements in the tumor suppressor gene PTEN in endometrial precancers as prognostic markers for cancer development: a population-based study from northern Norway with long-term follow-up.
Orbo A; Kaino T; Arnes M; Kopp M; Eklo K
Gynecol Oncol; 2004 Oct; 95(1):82-8. PubMed ID: 15385114
[TBL] [Abstract][Full Text] [Related]
35. Correlation between NDRG1 and PTEN expression in endometrial carcinoma.
Chen J; Li S; Yang Z; Lu G; Hu H
Cancer Sci; 2008 Apr; 99(4):706-10. PubMed ID: 18377423
[TBL] [Abstract][Full Text] [Related]
36. Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis.
Ali-Fehmi R; Khalifeh I; Bandyopadhyay S; Lawrence WD; Silva E; Liao D; Sarkar FH; Munkarah AR
Int J Gynecol Pathol; 2006 Jul; 25(3):223-9. PubMed ID: 16810057
[TBL] [Abstract][Full Text] [Related]
37. Histotype-genotype correlation in 36 high-grade endometrial carcinomas.
Hoang LN; McConechy MK; Köbel M; Han G; Rouzbahman M; Davidson B; Irving J; Ali RH; Leung S; McAlpine JN; Oliva E; Nucci MR; Soslow RA; Huntsman DG; Gilks CB; Lee CH
Am J Surg Pathol; 2013 Sep; 37(9):1421-32. PubMed ID: 24076778
[TBL] [Abstract][Full Text] [Related]
38. Unique biochemical properties of the protein tyrosine phosphatase activity of PTEN-demonstration of different active site structural requirements for phosphopeptide and phospholipid phosphatase activities of PTEN.
Chia JY; Gajewski JE; Xiao Y; Zhu HJ; Cheng HC
Biochim Biophys Acta; 2010 Sep; 1804(9):1785-95. PubMed ID: 20685300
[TBL] [Abstract][Full Text] [Related]
39. [Promoters of genes MTHFR from patients with hyperhomocysteinemia and PTEN from patients with malignant and benign endometrial and ovarian tumors].
Kovalenko TF; Vaniusheva OV; Shilov IA; Sosin DV; Sukhoverkhova AS; Kozlova TV; Bokarev IN; Sorokina AV; Ozolinia LA; Patrushev LI
Bioorg Khim; 2006; 32(4):414-23. PubMed ID: 16909866
[TBL] [Abstract][Full Text] [Related]
40. In Vitro and In Vivo Effects of Tumor Suppressor Gene PTEN on Endometriosis: An Experimental Study.
Lv J; Zhu Q; Jia X; Yu N; Li Q
Med Sci Monit; 2016 Oct; 22():3727-3736. PubMed ID: 27744455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
